CEIROX
LIVE

Serial Number

79237279

Owner

CeiROx Life Sciences SA

Filing Date

Apr 4, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CEIROX Trademark

Serial Number: 79237279 • Registration: 5940525

CEIROX is a trademark filed by CeiROx Life Sciences SA on April 4, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CeiROx Life Sciences SA

Rue de I'Eveche 5

Entity Type: 09

Trademark Details

Filing Date

April 4, 2018

Registration Date

December 24, 2019

Published for Opposition

October 8, 2019

Goods & Services

Pharmaceutical preparations in the nature of anti-inflammatory agents and anti-infectives, and for the treatment of disorders of the endocrine system, skin disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, metabolic disorders, ocular disorders, and for use in oncology; pharmaceuticals for the treatment of cancer, viral infections, neoplastic, metabolic, autoimmune or inflammatory disorders; chemico-pharmaceutical preparations, namely, for the prevention and treatment of cancer, viral infections, neoplastic, metabolic, autoimmune, inflammatory, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders; diagnostic preparations, chemical diagnostic and treatment preparations and chemical reagents for medical, pharmaceutical and veterinary purposes; biomedical products, namely, mixed biological preparations for the prevention and treatment of skin diseases, immune system disorders, cancer; living organs and tissues for surgical use; biological implants, namely, biological skin tissues; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the prevention and treatment of cancer, viral infections, neoplastic, metabolic, autoimmune, inflammatory, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders; skin grafts; all of the foregoing also available in time release formula

Medical services; medical clinic services; provision of medical information through websites, digital media and databases; providing medical information to doctors, patients and care givers via the Internet, digital media and databases; provision of medical services relating to the use of medical apparatus, instruments and devices; providing health information; providing medical information; medical diagnostic tests, monitoring and reporting services; medical services, namely, providing medical information relating to disease symptoms, medical experiences, support possibilities via an interactive platform for patients and care-givers; collection and preservation of biological tissue, blood and cells; medical-diagnostic services

Surgical, medical, dental and veterinary apparatus and instruments, namely, artificial organs and implants comprised of artificial materials; artificial skin for surgical purposes; surgical and wound care equipment, namely, drainage apparatus, suction apparatus, medical devices for closing wounds; diagnostic, examination and monitoring equipment, namely, blood pressure and diabetic diagnostic medical devices, flow cytometers for medical diagnostic uses, respiratory equipment and monitors therefor, patient monitors for critical care and anesthesia; diagnostic apparatus for medical purposes, namely, ultrasonic medical diagnostic apparatus, medical diagnostic apparatus for testing DNA and RNA samples; syringes for medical purposes; surgical instruments for skin surgery; all of the aforesaid goods being wholly or partly for administering medicine for the delayed, controlled or immediate release of the agents of pharmaceutical preparations

Scientific and technological services, namely, research and related design services in the field of medical technology, laboratory technology; research in the fields of pharmacy, medicine, biology, chemistry and laboratory technology; development, programming and implementation of software; IT consultancy, advisory and information services; creation of programs for data processing using information stored in databases; scientific analyses, namely, medical and pharmaceutical analyses; research services of a medical, biological, chemical laboratory; consulting, evaluation, research, testing, monitoring in the field of biology, bacteriology, chemistry for scientific research purposes; medical and pharmaceutical research services in the field of radiology, chemotherapy, hormone therapy, cell therapy, skin regeneration, regeneration of the joints; clinical research in the field of radiology, chemotherapy, hormone therapy, cell therapy, skin regeneration, regeneration of the joints; pharmaceutical research and development services; research and development in the field of biotechnology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2019 R.PR
PUBLISHED FOR OPPOSITION
Oct 8, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 4, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTICE OF PUBLICATION
Sep 18, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2019 CNSA
AMENDMENT FROM APPLICANT ENTERED
Aug 13, 2019 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2019 CRFA
PAPER RECEIVED
Aug 5, 2019 MAIL
FAX RECEIVED
Jul 31, 2019 FAXX
FINAL REFUSAL MAILED
Mar 27, 2019 CNFR
FINAL REFUSAL WRITTEN
Mar 26, 2019 CNFR
AMENDMENT FROM APPLICANT ENTERED
Feb 27, 2019 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2019 CRFA
PAPER RECEIVED
Feb 25, 2019 MAIL
ASSIGNED TO LIE
Feb 25, 2019 ALIE
FAX RECEIVED
Feb 18, 2019 FAXX
REFUSAL PROCESSED BY IB
Sep 8, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 23, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 23, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
Aug 15, 2018 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 14, 2018 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 1, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 31, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 31, 2018 MAFR
ASSIGNED TO EXAMINER
Jul 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 26, 2018 REPR